![CCR2-RA-[R]](https://file.medchemexpress.com/product_pic/hy-50081.gif "Click to View CCR2-RA-[R] Product Detail")
Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
236 Results for "
chemokine receptor
" in MedChemExpress (MCE) Product Catalog:
Products (236)
236 Results for "chemokine receptor" in MCE Product Catalog:
65
65 Publications Verification
Synonyms: Repertaxin; DF 1681Y
Target:
Research Areas:
Reparixin is a non-competitive allosteric inhibitor of the chemokine receptors CXCR1 and CXCR2 activation with IC50s of 1 and 100 nM, respectively.
65
65 Publications Verification
Synonyms: Repertaxin L-lysine salt
Target:
Research Areas:
Reparixin L-lysine salt is an allosteric inhibitor of chemokine receptor 1/2 (CXCR1/2) activation.
40
40 Cited Publications
Target:
Research Areas:
AMG 487 is an orally active and selective antagonist of CXC chemokine receptor 3 (CXCR3) which inhibits the binding of CXCL10 and CXCL11 to CXCR3 with IC50s of 8.0 and 8.2 nM, respectively .
33
33 Cited Publications
Target:
Research Areas:
RS 504393 is a selective CCR2 chemokine receptor antagonist (IC50 values are 89 nM and > 100 μM for inhibition of human recombinant CCR2 and CCR1 receptors respectively).
13
13 Cited Publications
Research Areas:
α-NETA is a potent and noncompetitive choline acetyltransferase (ChA) inhibitor with an IC50 of 9 μM. α-NETA is a potent ALDH1A1 (IC50=0.04 µM) and chemokine-like receptor-1 (CMKLR1) antagonist. α-NETA weakly inhibits cholinesterase (ChE; IC50=84 µM) and acetylcholinesterase (AChE; IC50=300 µM). α-NETA has anti-cancer activity .
11
11 Cited Publications
Cat. No.: HY-19855
CAS No.: 878385-84-3
Target:
Research Areas:
AZD-5069 is a potent CXCR2 chemokine receptor antagonist, used for caner treatment.
8
Research Areas:
Lysozyme (Muramidase) is a conserved antimicrobial protein. Lysozyme exerts its bactericidal effect by hydrolyzing bacterial cell wall peptidoglycan (PG). Lysozyme plays an important role in limiting bacterial growth on mucosal surfaces and other sites, not only controlling potential pathogens but also limiting overgrowth of microbiota to prevent dysbiosis. Extracellular lysozyme can also degrade polymeric PG into soluble fragments, activate NOD receptors in mucosal epithelial cells, and lead to the secretion of chemokines and activating factors by neutrophils and macrophages .
6
6 Cited Publications
Cat. No.: HY-U00064
CAS No.: 566203-88-1
Target:
Research Areas:
AZD2098 is a potent and selective CC-chemokine receptor 4 (CCR4) inhibitor with pIC50s of 7.8, 8.0, 8.0 and 7.6 for human, rat, mouse and dog respectively, used for asthma research .
5
Target:
4
4 Cited Publications
Cat. No.: HY-50081
CAS No.: 512177-83-2
Target:
Research Areas:
CCR2-RA-[R] is an allosteric antagonist of the C-C chemokine receptor type 2 (CCR2) with an IC50 of 103 nM.
4
4 Cited Publications
Cat. No.: HY-P0172
CAS No.: 1337878-62-2
Target:
Research Areas:
4
4 Cited Publications
Cat. No.: HY-P0172A
Target:
Research Areas:
4
4 Cited Publications
Cat. No.: HY-P1844
CAS No.: 676367-27-4
Research Areas:
4
4 Cited Publications
Cat. No.: HY-P1844A
Research Areas:
3
Research Areas:
CCR7 Ligand 1 (CCR7-Cmp2105) is an allosteric Ligand and antagonist for human CC chemokine receptor 7 (CCR7) with a Kd of 3 nM. CCR7 Ligand 1, thiadiazole-dioxide ligan, suppresses arrestin binding in response to activation by CCL19 with an IC50 of 7.3 μM .
3
3 Cited Publications
Cat. No.: HY-P7131
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: CXCL13; C-X-C Motif chemokine 13; Prev. SCYB13; CXC chemokine BLC; BCA-1; BCA1; BLC; B-Cell-Homing chemokine (Ligand For Burkitt'S Lymphoma receptor-1); ANGIE2; chemokine (C-X-C Motif) Ligand 13 (B-Cell Chemoattractant); BLR1L; chemokine (C-X-C Motif) Lig
Species:
Human
Source:
E. coli
3
3 Cited Publications
Target:
Research Areas:
C-021 is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively. C-021 effectively prevents human CCL22-derived [ 35S]GTPγS from binding to the receptor with an IC50 of 18 nM .
3
3 Cited Publications
Target:
Research Areas:
C-021 dihydrochloride is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 dihydrochloride potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively. C-021 dihydrochloride effectively prevents human CCL22-derived [ 35S]GTPγS from binding to the receptor with an IC50 of 18 nM .
3
3 Cited Publications
Target:
Research Areas:
BMS CCR2 22 is a potent, specific and high affinity CC-type chemokine receptor 2 (CCR2) antagonist with excellent binding affinity (binding IC50 of 5.1 nM) and potent functional antagonism (calcium flux IC50 of 18 nM and chemotaxis IC50 of 1 nM) .
2
2 Cited Publications
Target:
Research Areas:
CXCR7 antagonist-1 is a CXCR7 antagonist that inhibits the binding of the SDF-1 chemokine (also known as the CXCL12 chemokine) or I-TAC (also known as CXCL11) to the chemokine receptor CXCR7. CXCR7 antagonist-1 is useful in preventing tumor cell proliferation, tumor formation, inflammatory diseases, and many other diseases .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
